Medicaid Coverage and Reimbursement of Antiobesity Medications across States
Healthcare ECONOMIST
MARCH 17, 2024
Medicaid policies vary from state-to-state. With the advent of new, GLP-1 medications (and others) to treat obesity and overweight, there are potentially significant health benefits to be gained. However, are State Medicaid Agencies actually covering these medications? This is the question asked by Liu et al. (2024). They use data from public state Medicaid formulary and preferred drug list files to determine if a state covered FDA-approved anti-obesity medications.
Let's personalize your content